help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0343
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanda, N.
Right arrow Articles by Watanabe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanda, N.
Right arrow Articles by Watanabe, S.
Endocrinology Vol. 149, No. 10 5189-5198
Copyright © 2008 by The Endocrine Society

Leptin Enhances Human β-Defensin-2 Production in Human Keratinocytes

Naoko Kanda and Shinichi Watanabe

Department of Dermatology, Teikyo University School of Medicine, Tokyo 173-8605, Japan

Address all correspondence and requests for reprints to: Dr. Naoko Kanda, Department of Dermatology, Teikyo University School of Medicine, 11-1 Kaga-2 Itabashi-Ku, Tokyo 173-8605, Japan. E-mail: nmk{at}med.teikyo-u.ac.jp.

Leptin, an adipocyte-derived cytokine/hormone, modulates innate and adaptive immunity. Human β-defensin-2 (hBD-2) produced by epidermal keratinocytes promotes cutaneous antimicrobial defense, inflammation, and wound repair. We examined the in vitro effects of leptin on hBD-2 production in human keratinocytes. hBD-2 secretion and mRNA expression were analyzed by ELISA and RT-PCR, respectively. Although leptin alone was ineffective, it enhanced IL-1β-induced hBD-2 secretion and mRNA expression in keratinocytes. IL-1β- and IL-1β plus leptin-induced hBD-2 production both were suppressed by antisense oligonucleotides against nuclear factor-{kappa}B (NF-{kappa}B) p50 and p65; the latter was also suppressed by antisense signal transducer and activator of transcription (STAT)1 and STAT3. IL-1β enhanced the transcriptional activity of NF-{kappa}B, whereas leptin enhanced STAT1 and STAT3 activity. The p38 MAPK inhibitor SB202190 suppressed IL-1β- and IL-1β plus leptin-induced hBD-2 production, IL-1β-induced NF-{kappa}B activity, and leptin-induced STAT1 and STAT3 activity; contrastingly, the Janus kinase (JAK) 2 inhibitor AG490 suppressed IL-1β plus leptin-induced hBD-2 production and leptin-induced STAT1 and STAT3 activity. IL-1β induced serine phosphorylation of inhibitory {kappa}B{alpha}, STAT1, and STAT3. Leptin induced tyrosine and serine phosphorylation of STAT1 and STAT3, both of which were suppressed by AG490, and serine phosphorylation was also suppressed by SB202190. IL-1β or leptin individually induced threonine/tyrosine phosphorylation of p38 MAPK, whereas only leptin induced tyrosine phosphorylation of JAK2, suggesting that leptin may enhance hBD-2 production in keratinocytes by activating STAT1 and STAT3 via JAK2 and p38 MAPK in cooperation with NF-{kappa}B, which is activated by IL-1β. Leptin may promote cutaneous antimicrobial defense, inflammation, and wound repair via hBD-2.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society